Latest news with #NSEs
Business Standard
07-08-2025
- Business
- Business Standard
NSE SME Aaradhya Disposal Industries IPO ends with 1.39 times subscription
The offer received bids for 54.25 lakh shares as against 38.88 lakh shares on offer. The initial public offer (IPO) of Aaradhya Disposal Industries received bids for 54,25,200 shares as against 38,88,000 shares on offer. The issue was subscribed 1.39 times. Qualified Institutional Buyers (QIBs) bid for 4,63,200 shares, Non-Institutional Investors (NIIs) for 23,89,200 shares, while Retail Individual Investors (RIIs) placed bids for 25,72,800 shares. The issue opened for bidding on 04 August 2025 and it closed on 06 August 2025. The price band of the IPO was set at Rs 110 to Rs 116 per share. The equity shares will list on NSEs SME platform. The IPO comprises fresh issue of 38,88,000 equity shares. The promoter and promoter group shareholding dilute to 70.58% from 97.36% pre-issue. The company intends to utilize the net proceeds for working capital requirement, to fund the expansion plan of the company i.e. capital expenditure towards purchase of plant and machinery and civil work, prepayment of term loans to banks and general corporate purpose. Aaradhya Disposal is a leading manufacturer and supplier of high-quality paper products serving a diverse range of industries both domestically and internationally. With over a decade of expertise, the company offers an extensive selection of paper-based solutions, including paper cup blanks with PE, PLA, and barrier coatings. Their product portfolio also features a variety of food-grade papers such as greaseproof paper, greaseproof 4K paper, greaseproof slip-easy paper, wet strength greaseproof, oil and grease resistant (OGR) paper, vegetable parchment paper, and titanium dioxide (TDL) poster paper. As of 30 June 2025, the company had 33 permanent employees. The company recorded revenue from operations of Rs 113.69 crore and net profit of Rs 10.27 crore for the period ended 31 March 2025.
Business Standard
06-08-2025
- Business
- Business Standard
NSE Indices launches Nifty Total Market Momentum Quality 50 Index
NSEs index services subsidiary NSE Indices has launched a new strategy index Nifty Total Market Momentum Quality 50 index that aims to track the performance of a 50-stock portfolio selected based on a combination of momentum and quality factors from the Nifty Total Market. The momentum score for each company is determined based on its 6-month and 12-month price return, adjusted for volatility. The quality score for each company is determined based on return on equity (ROE), financial leverage (debt/equity ratio) and earnings (EPS) growth variability analyzed during the previous 5 years. The weight of each stock in the index is based on a combination of its composite factor score and free float market capitalization and is capped at the lower of 5% or 5 times its weight in the index based on free float market capitalization. The index has a base date of 01 April 2005, and a base value of 1000. It will be reconstituted and rebalanced semi-annually. As of 31 July 2025, the index delivered a 1-year total return of (-12.11)%. It has, however, recorded a strong 21.70% CAGR since inception. Top constituents include: Coromandel International (5.63%), Maruti Suzuki India (5.21%), Divi's Laboratories (5.18%), Eicher Motors (5.05%) and Hindustan Aeronautics (4.84%). The new index is expected to act as a benchmark for asset managers and be a reference index tracked by passive funds in the form of Exchange Traded Funds (ETFs), index funds and structured products.
Business Standard
28-05-2025
- Business
- Business Standard
NSE SME IPO of N R Vandana Tex Industries subscribed 1.37 times
The offer received bids for 60.63 lakh shares as against 44.37 lakh shares on offer. The initial public offer (IPO) of Neptune Petrochemicals received bids for 60,63,000 shares as against 44,37,000 shares on offer, as per NSE data as of 17:00 hours on Wednesday (28 May 2025). The issue was subscribed 1.37 times. The issue opened for bidding on Wednesday (28 May 2025) and it will close on Friday (30 May 2025). The price band of the IPO is fixed between Rs 42 to Rs 45 per share. The minimum order quantity is 3,000 equity shares. The equity shares will list on NSEs SME platform. The IPO comprises fresh issue of 61,98,000 equity shares. About 3,12,000 equity shares will be reserved for subscription by market maker to the issue. The net issue comprises of 58,86,000 equity shares including anchor allocation portion. The company intends to utilize the net proceeds for funding working capital requirements, prepayment or repayment of loans, and general corporate purposes. Ahead of the Neptune Petrochemicals on Tuesday, 27 May 2025, raised Rs 7.92 crore from anchor investors. The board has allotted 17.61 lakh shares at Rs 45 per share to 6 anchor investors. Neptune Petrochemicals is engaged in the design, manufacturing, and wholesale of cotton textile products, including a variety of high-quality cotton sarees, salwar suits, and bed sheets. Its products are recognized in the textile industry under the brand names Vandana and Tanaya. The company operates a B2B business model, focusing on selling products through a network of 1,397 wholesalers as of 31 March 2025, spread across 31 states and union territories in India, as well as through a B2B e-commerce platform. As of 30 April 2025, the company had 86 employees and 34 persons working as contract labour. The company recorded revenue from operations of Rs 270.80 crore and net profit of Rs 8.60 crore for the period ended 31 March 2025.
Business Standard
21-05-2025
- Business
- Business Standard
NSE SME IPO of Dar Credit & Capital subscribed 5.35 times
The offer received bids for 1.63 crore shares as against 30.60 lakh shares on offer. The initial public offer (IPO) of Dar Credit & Capital received bids for 1,63,76,000 shares as against 30,60,000 shares on offer, as per NSE data as of 17:00 hours on Wednesday (21 May 2025). The issue was subscribed 5.35 times. The issue opened for bidding on Wednesday (21 May 2025) and it will close on Friday (23 May 2025). The price band of the IPO is fixed between Rs 57 to Rs 60 per share. The minimum order quantity is 2,000 equity shares. The equity shares will list on NSEs SME platform. The IPO comprises fresh issue of 42,76,000 equity shares. About 2,16,000 equity shares will be reserved for subscription by market maker to the issue. The net issue comprises of 40,60,000 equity shares including anchor allocation portion. The company intends to utilize the net proceeds to meet the issue expenses, to augment the capital base of the company and general corporate purposes. Ahead of the Dar Credit & Capital on Tuesday, 20 May 2025, raised Rs 7.29 crore from anchor investors. The board has allotted 12.16 lakh shares at Rs 60 per share to 6 anchor investors. Dar Credit & Capital offers three primary types of financial products: (i) Personal Loans, (ii) Unsecured MSME Loans, and (iii) Secured MSME Loans. The company specializes in providing credit solutions to low-income individuals, particularly those employed in Class IV (Group D) roles such as cleaners, sweepers, and peons working in municipal bodies. It also extends credit to small-scale shopkeepers, traders, manufacturers, individuals engaged in agriculture and allied activities, and local vendors, with a strong focus on empowering women entrepreneurs. With extensive experience in Indias financing and investment sector, Dar Credit & Capital has built a deep understanding of the market since its inception. As of 31 December 2024, the company had 224 full-time employees. The company recorded revenue from operations of Rs 30.09 crore and net profit of Rs 4.92 crore for the period ended 31 December 2024.
Business Standard
19-05-2025
- Business
- Business Standard
NSE SME Accretion Pharmaceuticals' IPO ends with subscription of 7.31 times
The offer received bids for 2 crore shares as against 27.35 lakh shares on offer. The initial public offer (IPO) of Accretion Pharmaceuticals received bids for 2,00,06,400 shares as against 27,34,800 shares on offer. The issue was subscribed 7.31 times. Retail investors bid for 1,28,95,200 shares, non-institutional investors bid for 53,91,600 shares and qualified institutional investors bid for 17,19,600 shares. The issue opened for bidding on 14 May 2025 and it closed on 16 May 2025. The price band of the IPO was set at Rs 96 to Rs 101 per share. The equity shares will list on NSEs SME platform. The IPO comprised fresh issue of 29,46,000 equity shares. The promoter and promoter group shareholding diluted to 73.14% from 100% pre-issue. The company intends to utilize the net proceeds for capital expenditure towards the purchase of new equipment and machinery, capital expenditure for the upgradation of the existing manufacturing facility, repayment or prepayment of certain borrowings availed by the company, funding of working capital requirements and for general corporate purposes. Ahead of the Accretion Pharmaceuticals on 13 May 2025, raised Rs 2.13 crore from anchor investors. The company allotted 2.11 lakh shares at Rs 101 per share to 2 anchor investors. Accretion Pharmaceuticals is engaged in the business of manufacturing and marketing tablets, capsules, oral liquids, external preparations (ointments, creams, gels, lotions, medicated shampoos, mouthwash, dusting powder), and oral powders (sachets, dry syrup), etc. Apart from manufacturing products for direct sales, the company also manufactures various pharmaceutical products for different marketers on a loan license or contract manufacturing basis. Its business is primarily carried out on a principal-to-principal basis with different marketers. The company had a total of 105 employees. The company recorded revenue from operations of Rs 35.67 crore and net profit of Rs 5.24 crore for the period ended 31 December 2024.
